Nuvectis Pharma Inc
NASDAQ:NVCT
Nuvectis Pharma Inc
NASDAQ:NVCT
Price:
8.92
USD
1.83%
Market Closed
Market Cap:
$228.4m
Balance Sheet
Balance Sheet Decomposition
Nuvectis Pharma Inc
Nuvectis Pharma Inc
Balance Sheet Decomposition is not available for
Nuvectis Pharma Inc
Nuvectis Pharma Inc
Balance Sheet
Nuvectis Pharma Inc
Nuvectis Pharma Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
6
|
20
|
19
|
19
|
32
|
|
| Cash Equivalents |
0
|
6
|
20
|
19
|
19
|
32
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
6
|
20
|
19
|
19
|
32
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
7
N/A
|
20
+206%
|
19
-6%
|
19
-3%
|
32
+70%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
3
|
3
|
2
|
6
|
|
| Accrued Liabilities |
0
|
1
|
3
|
4
|
6
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
6
|
7
|
9
|
13
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
2
+24 100%
|
6
+156%
|
7
+13%
|
9
+27%
|
13
+49%
|
|
| Equity | |||||||
| Common Stock |
0
|
15
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
13
|
32
|
54
|
73
|
100
|
|
| Additional Paid In Capital |
0
|
2
|
46
|
66
|
83
|
118
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
4
N/A
|
14
+235%
|
12
-14%
|
10
-20%
|
18
+90%
|
|
| Total Liabilities & Equity |
0
N/A
|
7
N/A
|
20
+206%
|
19
-6%
|
19
-3%
|
32
+70%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
0
|
0
|
15
|
17
|
19
|
26
|
|
Switch to:
Switch to:
See Also
Discover More
